Back

Sex-specific differences in lipoprotein (a) levels and their shared impact on coronary artery disease extent in ACS

28 August 2026 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Lp(a), triglycerides and coronary artery disease Lipids ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Francisco Buendia Santiago

General University Hospital Santa Lucia, Cartagena (Spain)

5 More presentations in this session

Presentation thumbnail
Insulin resistance surpasses remnant cholesterol: the triglyceride–glucose index as a stronger predictor of coronary artery disease
Doctor F. Sousa (Funchal, PT)
Abstract Slides
Presentation thumbnail
Cumulative LDL-cholesterol exposure after Index percutaneous coronary intervention and subsequent major adverse cardiac and cerebrovascular events
Doctor S. KAGEYAMA (Shizuoka, JP)
Abstract Slides
Presentation thumbnail
Transient surge, persistent risk: longitudinal changes in lipoprotein(a) following acute coronary syndrome
Doctor K. Mahajan (Mandi, IN)
Abstract Slides
Presentation thumbnail
Lipoprotein(a) adds no predictive value for coronary disease beyond traditional risk factors
Professor M. Banach (Lodz, PL)
Abstract Slides
Presentation thumbnail
Remnant cholesterol: an independent determinant of coronary artery disease and future cardiovascular events beyond traditional risk factors
Doctor F. Sousa (Funchal, PT)
Abstract Slides

Access the full session

Session thumbnail
Lp(a), triglycerides and coronary artery disease

The Event

Event poster

ESC Congress 2026

28 August 2026 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Sex-specific influence of lipoprotein(a) levels on coronary plaque characteristics: the COPRODUCTION-registry
1 September 2025
thumbnail
Congress Presentation
Understanding sex-based differences in acute coronary syndrome
21 March 2026
thumbnail
Congress Presentation
Lipoprotein(a) levels in acute coronary syndrome: analysis of sex, age, and cardiovascular risk factors
19 May 2025
thumbnail
Congress Presentation
Sex-specific drug-target Mendelian randomisation on the effects of lipid-modifying targets on cardiovascular disease
4 April 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources